CVSH34
R$32.34
0.00%
Stock
CVS Health Corporation
Official Company Name: CVS Health Corporation
Stock Symbol: CVSH34
Stock Market: B3 - Bovespa
Currency: Brazilian real - BRL
CVSH34 Stock Price - 1 Year Price Evolution & Moving Averages
1 Year Return
▼-4.43%
Daily closing prices, with moving averages and volumes - Brazilian real (BRL)
Moving averages:
- — EMA20
- — SMA50
- — SMA200
CVS Health Categories
United States
languages
Healthcare
languages
Healthcare Plans
Healthcare
Healthcare Plans
Company Description
CVS Health is a healthcare company primarily operating in pharmacy retail, drug prescription benefits, health insurance, medical facilities, and services. The company’s flagship business and brand, CVS Pharmacy, manages more than 9,000 stores across the US. Other key businesses include CVS Caremark which provides prescription benefit management services, CVS Specialty, a chronic and genetic therapy pharmacy division, and the retail medical clinic MinuteClinic.
CVSH34 Stock Data
| Open | R$32.34 |
| High | R$32.34 |
| Low | R$32.34 |
| Close | R$32.34 |
| Volume | 0 |
| Previous Close | R$32.34 |
| 1-Day Change | 0.00 |
| 1-Year Change | -1.50 |
| Average Daily Volume | 620 |
| 52-Week High | R$40.21 |
| 52-Week Low | R$27.78 |
Disclaimer
All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!
Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.
Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).
Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.
Please conduct your own due diligence to verify insights.